NCT07473050Not yet recruiting
Virtual Reality-Based 'Health at My Feet' Program for Individuals With Type 2 Diabetes
Virtual Reality-Based 'Health at My Feet' Program for Individuals With Type 2 Diabetes: A Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 16 Mar 2026
Brief summary (registry, in English)
This randomized controlled experimental study aims to develop and evaluate the effectiveness of a Virtual Reality-Based "Health to My Foot" program designed for individuals with Type II Diabetes Mellitus. The study will assess the program's impact on diabetic foot knowledge, foot care self-efficacy, foot care behaviors, and foot health outcomes. The research will be conducted between April and October 2026 at a university hospital diabetes outpatient clinic in İzmir, Türkiye. A total of 70 participants diagnosed with Type II DM will be enrolled and randomly assigned to either the intervention group (n=35) or the control group (n=35) using stratified block randomization. Participants in the intervention group will receive the Virtual Reality-Based "Health to My Foot" program through virtual reality goggles and will have access to a recorded foot care training video for home use. They will also receive weekly motivational reminder messages for three months. The control group will receive standard outpatient care only. Data will be collected at baseline (pre-test), 1 month (post-test), and 3 months (follow-up) using validated scales and a nurse follow-up form to evaluate knowledge, self-efficacy, behaviors, and clinical foot health indicators. The findings are expected to contribute to sustainable patient education strategies and to support the prevention of diabetic foot complications and reduction of healthcare costs.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 2 Mar 2026
- Start date
- 16 Apr 2026
- Primary completion date
- 30 May 2026
- Lead sponsor
- Ege University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07473050
What you commit to
- Study type: Interventional
- Planned participants: 70
- From 16 Apr 2026 to the primary completion date, 30 May 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having previously had a diabetic foot ulcer or currently having a diabetic foot ulcer
- \- Risk level 3 according to the International Working Group on the Diabetic Foot (IWGDF) Risk Level Classification
Other illness
- Having a severe/uncontrolled comorbid disease
Other
- Wishing to withdraw from the study
Who the study is looking for
- Being over 18 years of age
- Having been diagnosed with type 2 diabetes for at least one year
- Having a risk level of 0, 1, or 2 according to the International Working Group on the Diabetic Foot (IWGDF) Risk Level Classification
- Having completed primary education or higher
- Not having hearing, speech, or visual impairments
- Being able to use a smartphone
- Not having received prior training in diabetic foot care
- Being willing to participate in the study
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.